9 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... LAMA: long-acting ... #Management #Pulmonary ... COPD #GOLD2017 #LAMA
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... long-acting β2-agonist; LAMA ... #Algorithm #Management ... #Pulmonary #LABA ... #LAMA #SABA #SAMA
There is a hydropneumothorax.
Notice the air-fluid level (blue arrow).
The upper lobe is still attached to the
lymphangioleiomyomatosis (LAM ... LAM is a rare lung ... to pulmonary cyst ... LAM also occurs ... Lymphangioleiomyomatosis #LAM
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
macrophages and T cells ... involvement - seeding ... Tuberculosis Treatment ... Initiating Treatment ... Diagnosis #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
macrophages and T cells ... involvement - seeding ... Tuberculosis Treatment ... Initiating Treatment ... Diagnosis #Management #Treatment
There is a hydropneumothorax.
Notice the air-fluid level.
The upper lobe is still attached to the chest wall
lymphangioleiomyomatosis (LAM ... LAM is a rare lung ... to pulmonary cyst ... LAM also occurs ... Lymphangioleiomyomatosis #LAM
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... is vital while lab ... causing hypovolemia needing ... #differential #algorithm ... #management #cardiology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
primary) • Anti-La ... Disease: • 10%-15% Pulmonary ... , INC risk PE, Pulmonary ... Adenocarcinoma Treatment ... muscarinic agonists • Active
Lymphangioleiomyomatosis- Computed tomography of the chest, reconstructed in the coronal plane at the level of the
intraparenchymal pulmonary ... Spindle cells coexpressing ... Lymphangioleiomyomatosis #LAM ... #radiology #CT